Mersana Therapeutics to Present Preclinical Data from Immunosynthen STING-Agonist ADC Platform at the Society for Immunotherapy of Cancer (SITC) 35th Anniversary Annual Meeting

Written by Customer Service on October 14, 2020. Posted in Public Companies.

CAMBRIDGE, Mass., Oct. 14, 2020 (GLOBE NEWSWIRE) — Mersana Therapeutics, Inc. (NASDAQ:MRSN), a clinical-stage biopharmaceutical company focused on discovering and developing a pipeline of antibody-drug conjugates (ADCs) targeting cancers in areas of high unmet medical need, today announced that it will present preclinical data from its novel Immunosynthen STING-agonist ADC platform at the 35th Annual Meeting of the Society for Immunotherapy of Cancer (SITC) taking place virtually from November 9-14, 2020. Details of the poster display are as follows:Poster Title: Tumor cell-intrinsic STING pathway is activated in the presence of cues from immune cells and contributes to the anti-tumor activity of tumor cell-targeted STING agonist antibody-drug conjugatesAbstract Number: 620E-poster Available: 9 a.m. – 5 p.m. ET, November 11-14,...

Silvercorp Intersects 2.28 Metres Grading 1,125 g/t Silver, 4.43% Lead, 0.40% Zinc, 0.06 g/t Gold, and 0.23% Copper in the 2020 Exploration Program at the TLP Mine, Ying Mining District, China

Written by Customer Service on October 14, 2020. Posted in Public Companies.

VANCOUVER, British Columbia, Oct. 14, 2020 (GLOBE NEWSWIRE) — Silvercorp Metals Inc. (“Silvercorp” or the “Company”) (TSX/NYSE American: SVM) is pleased to report results of its exploration program at the TLP mine, Ying Mining District, Henan Province, China. Extensive exploration drilling and tunneling are ongoing at the TLP mine, and all other mines at the Ying Mining District.From October 1, 2019 to September 30, 2020, the drilling program at the TLP mine has targeted the down/up dip and along-strike extensions of known mineralized vein structures in the production areas. So far, 26,355 metres (“m”) from a total of 110 diamond drill holes, including 106 underground holes and four surface holes, have been completed. Assay results for 71 holes have been received with 48 holes intercepting mineralization.Most of the underground...

Neoleukin Therapeutics Announces Abstract Accepted for Presentation at the Society for Immunotherapy of Cancer’s 35th Anniversary Annual Meeting (SITC 2020)

Written by Customer Service on October 14, 2020. Posted in Public Companies.

SEATTLE, Oct. 14, 2020 (GLOBE NEWSWIRE) — Neoleukin Therapeutics, Inc., “Neoleukin” (NASDAQ:NLTX), a biopharmaceutical company utilizing sophisticated computational methods to design de novo protein therapeutics, today announced the acceptance of a preclinical data abstract on its lead therapeutic candidate, NL-201, at the Society for Immunotherapy of Cancer’s 35th Anniversary Annual Meeting (SITC 2020) taking place November 9 to November 14, 2020 in a virtual format.Details of the poster presentation are as follows:Title: NL-201, a de novo IL-2/IL-15 agonist, demonstrates enhanced in vivo antitumor activity in combination with multiple cancer immunotherapiesAbstract: 576Authors: Carl Walkey, Ryan Swanson, Kevin Yu, Umut Ulge, Daniel Silva, and Jonathan Drachman of Neoleukin TherapeuticsePoster presentation times including live...

Iovance Biotherapeutics to Present Clinical Data in Head and Neck Cancer at Society for Immunotherapy of Cancer (SITC) 35th Annual Meeting

Written by Customer Service on October 14, 2020. Posted in Public Companies.

SAN CARLOS, Calif., Oct. 14, 2020 (GLOBE NEWSWIRE) — Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a late-stage biotechnology company developing novel T cell-based cancer immunotherapies, today announced that new interim clinical data for the tumor infiltrating lymphocyte (TIL) therapy LN-145 in combination with pembrolizumab in head and neck squamous cell carcinoma (HNSCC) will be presented at the 35th Anniversary Annual Meeting of the Society for Immunotherapy of Cancer (SITC). The SITC 35th Annual Meeting will be held virtually from November 9-14, 2020. Details of the poster are as follows:Title: Safety and efficacy of tumor infiltrating lymphocytes (TIL; LN-145) in combination with pembrolizumab for advanced, recurrent or metastatic HNSCCAuthors: A Jimeno, et al.About Iovance Biotherapeutics, Inc.Forward-Looking StatementsCertain...

Innospec Publishes 2019 Responsible Business Report

Written by Customer Service on October 14, 2020. Posted in Public Companies.

ENGLEWOOD, Colo., Oct. 14, 2020 (GLOBE NEWSWIRE) — Innospec (NASDAQ: IOSP) today announced the publication of its 2019 Responsible Business Report. The report provides an overview of the company’s progress and on-going commitment to corporate responsibility and sustainability.Key highlights from 2019 include:Continued focus on the reduction of Greenhouse Gas (GHG) emissions, energy and water usage, including a 5 percent reduction in absolute GHG emissions compared to 2018;EcoVadis Gold Medal awarded for Innospec’s sustainability performance across environment, labor and fair business practices;Over US$517,000 raised to support 136 worldwide charities and good causes local to our operations through our Innospec Cares program and the expansion to include employee-volunteering days;Over US$1 million raised for the PenFed Foundation...

QEP Resources Announces Third Quarter 2020 Financial and Operational Results Release Date and Conference Call

Written by Customer Service on October 14, 2020. Posted in Public Companies.

DENVER, Oct. 14, 2020 (GLOBE NEWSWIRE) — QEP Resources, Inc. (NYSE: QEP) announced today that it will host a teleconference and webcast to discuss its third quarter 2020 results beginning at 9:00 a.m. ET (7:00 a.m. MT) on Thursday, October 29, 2020. QEP will issue a news release containing third quarter 2020 financial and operational results on Wednesday, October 28, 2020, after market close.The conference call can be heard live through a link on the QEP website, www.qepres.com. In addition, you may participate in the conference call by dialing (877) 869-3847 domestically or (201) 689-8261 internationally. Attendees should log in to the webcast or dial in approximately 15 minutes prior to the call’s start time. A replay of the conference call will be available on the QEP website and a telephone audio replay will be available from...

Altus Midstream Company to Host Third-Quarter 2020 Results Conference Call Nov. 5 at 1 P.M. Central Time

Written by Customer Service on October 14, 2020. Posted in Public Companies.

HOUSTON, Oct. 14, 2020 (GLOBE NEWSWIRE) — Altus Midstream Company (Nasdaq: ALTM) (“Altus”) will host its third-quarter 2020 results conference call Thursday, Nov. 5, 2020, at 1 p.m. Central time. The company will issue its earnings release after close of market Wednesday, Nov. 4. The full text of the release will be available on the company’s website at www.altusmidstream.com.The conference call will be webcast from Altus’ website at www.altusmidstream.com/investors, and the webcast replay will be archived there as well. The conference call will also be available for playback by telephone for one week beginning at approximately 6 p.m. Central time Nov. 5. To access the telephone playback, dial (855) 859-2056 or (404) 537-3406 for international calls. The conference access code is 3645066.About Altus MidstreamAltus Midstream...

Apache Corporation Provides Third-Quarter Supplemental Information and Schedules Results Conference Call for Nov. 5, 2020, at 10 A.M. Central Time

Written by Customer Service on October 14, 2020. Posted in Public Companies.

HOUSTON, Oct. 14, 2020 (GLOBE NEWSWIRE) — Apache Corporation (Nasdaq: APA) today provided supplemental information regarding certain third-quarter 2020 financial and operational results.Supplemental quarterly informationTo further assist analysts with their third-quarter earnings models, the company is providing the following estimates:Third-quarter 2020 earnings callApache Corporation will host its third-quarter 2020 results conference call on Thursday, Nov. 5, 2020, at 10 a.m. Central time. The company will issue its earnings release after the market close on Wednesday, Nov. 4. The full text of the release will be available on the company’s website at www.apachecorp.com. The conference call will be webcast from Apache’s website at investor.apachecorp.com, and the webcast replay will be archived there as well. The conference...

OceanaGold Announces Filing of Final Prospectus For C$150 Million Bought Deal Offering of Common Shares

Written by Customer Service on October 14, 2020. Posted in Public Companies.

NOT FOR DISSEMINATION OR DISTRIBUTION IN THE UNITED STATES AND NOT FOR DISTRIBUTION TO US NEWSWIRE SERVICES.BRISBANE, Australia, Oct. 14, 2020 (GLOBE NEWSWIRE) — OceanaGold Corporation (TSX: OGC) (ASX: OGC) (the “Company”) announces that it has today filed a final short form prospectus in connection with its previously announced bought deal financing. The Company previously entered into an agreement with a syndicate of underwriters (the “Underwriters”), led by Scotiabank and BMO Capital Markets, who have agreed to purchase, on a bought deal basis, an aggregate of 73,000,000 common shares (the “Offered Shares”) of the Company at a price of C$2.06 per Offered Share (the “Offering Price”), for aggregate gross proceeds of C$150 million (the “Offering”).The Company has also granted the Underwriters the option, exercisable...

Communiqué: Orange announces the results of its tender offer to repurchase its Non-Call Deeply Subordinated Fixed to Reset Rate Notes

Written by Customer Service on October 14, 2020. Posted in Public Companies.

Press releaseParis, 14 October 2020Not for distribution in the United States of AmericaORANGE announces the results of its tender offer to repurchase its€1,000,000,000 Undated 7 Year Non-Call Deeply Subordinated Fixed to Reset Rate Noteswith first call date on 1 October 2021(ISIN XS1115490523)and/or£650,000,000 Undated 8 Year Non-Call Deeply Subordinated Fixed to Reset Rate Noteswith first call date on 7 February 2022(ISIN XS1028597315)and/or£600,000,000 Undated 8.5 Year Non-Call Deeply Subordinated Fixed to Reset Rate Notes with first call date on 1 April 2023(ISIN XS1115502988)ORANGE S.A. (the Company) is pleased to announce:the signing of its issuance of €700,000,000 undated 8 year non-call deeply subordinated fixed to reset rate notes (the New Notes) with a fixed coupon of 1.750% until the first call date; andthe results of its tender...

Day: October 14, 2020

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Cookie Notice